BIOADAPTIVES, INC. (BDPT)

AI-Powered SEC Filing Analysis

Insider Trading Filed: 2026-05-05

Key Insights

  • Director Mark P. Frissora received 4,808 shares of Series D Convertible Preferred Stock on 05/01/2026 as board compensation, demonstrating continued director engagement and alignment with the company.
  • The preferred shares convert to 480,800 common shares at a 100:1 ratio but are subject to a 4.9% beneficial ownership limitation, indicating anti-dilution protections are in place for the company.
  • Conversion is restricted for six months from issuance (until 11/01/2026) except in liquidation events, suggesting the company has structured vesting to retain insider commitment through mid-November 2026.
  • The preferred shares carry 100 votes per share without ownership limitations for voting purposes, granting Frissora significant voting power (480,800 votes) despite the conversion cap.
Annual Report Filed: 2026-04-14

Key Insights

  • The company has experienced a significant increase in revenue over the past fiscal year, growing from $89 million to $1.25 billion, indicating strong market demand for its products.
  • The company's net income has remained stable at $8.2 million and $12 million in the last two fiscal years, suggesting efficient cost management and profitability.
  • The company has raised substantial capital through the issuance of various preferred stock series and convertible notes, totaling $66 million, which could be used to fund growth initiatives and expansion.
Insider Trading Filed: 2026-03-03

Key Insights

  • The reporting person, Mark P. Frissora, has acquired 2,578 shares of Series D Convertible Preferred Stock of BioAdaptives, Inc. (BDPT), which are convertible into 257,800 shares of common stock.
  • The Series D Convertible Preferred Stock was issued as compensation for Frissora's board services, indicating his continued involvement and commitment to the company.
  • The convertible preferred shares have a 4.9% beneficial ownership limitation, which may limit Frissora's ability to exercise full control over the company.

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.